Fate Therapeutics Inc
F:F6T
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fate Therapeutics Inc
F:F6T
|
US |
|
I
|
Invitae Corp
F:IV8
|
US |
|
F
|
FTAC Emerald Acquisition Corp
OTC:FLDD
|
US |
|
F
|
Futuristic Securities Ltd
BSE:523113
|
IN |
|
C
|
China Skyrise Digital Service Inc
OTC:CSKD
|
CN |
|
Restaurant Group PLC
LSE:RTN
|
UK |
|
C
|
Country View Bhd
KLSE:CVIEW
|
MY |
|
B
|
B & A Ltd
BSE:508136
|
IN |
|
C
|
Conn's Inc
F:CN4
|
US |
|
M
|
Munic SA
F:MNS
|
FR |
|
Goodbye Kansas Group AB
F:3MB
|
SE |
|
P
|
PRG Corporation PCL
SET:PRG
|
TH |
|
S
|
SLJ Global Tbk PT
XMUN:LF9
|
ID |
|
Roth CH Acquisition Co
OTC:USCTF
|
US |
|
Q
|
Queensland Gold Hills Corp
XTSX:OZAU
|
CA |
|
I
|
iWin Plus Co Ltd
KOSDAQ:123010
|
KR |
|
C
|
China Mining International Ltd
SGX:BHD
|
SG |
|
R
|
Remedis SA
WSE:REM
|
PL |
|
Enertopia Corp
OTC:ENRT
|
CA |
|
Envit Capital Group Inc
OTC:ECGP
|
US |
Wall St Price Targets
F6T Price Targets Summary
Fate Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
F6T is 2.949 EUR with a low forecast of 1.15 EUR and a high forecast of 4.346 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is F6T's stock price target?
Price Target
2.949
EUR
According to Wall Street analysts, the average 1-year price target for
F6T is 2.949 EUR with a low forecast of 1.15 EUR and a high forecast of 4.346 EUR.
What is the Revenue forecast for Fate Therapeutics Inc?
Projected CAGR
70%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is 70%.